Health Condition 1: F314- Bipolar disorder, current episodedepressed, severe, without psychotic features Health Condition 2: F311- Bipolar disorder, current episodemanic without psychotic features Health Condition 3: F23- Brief psychotic disorder Health Condition 4: F331- Major depressive disorder, recurrent, moderate Health Condition 5: F323- Major depressive disorder, singleepisode, severe with psychotic features Health Condition 6: F322- Major depressive disorder, singleepisode, severe withou
Conditions
Interventions
Intervention1: Low dose propofol in electroconvulsive therapy: Propofol in the dose of 1mg/kg is given for one session of Electroconvulsive therapy, seizure duration is noted
Control Intervention1: Et
Sponsors
Dr Praveen Onimath
Eligibility
Inclusion criteria
Inclusion criteria: ASA Physical status I and II Age 20-65 years Informed valid written consent taken from patients attenders
Exclusion criteria
Exclusion criteria: History of allergy to given drug History of cardiovascular diseases History of cerebrovascular diseases with raised ICT Uncontrolled seizures on antiepileptics Patients on pacemaker Neuromuscular diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effects of low dose propofol and etomidate on seizure duration and seizure thresholdTimepoint: HR, BP, SPO2 are noted after the administration of study drug, after giving succinylcholine, then after ECT, at 1, 3, 5,7, 10 min, and then every 5 min throughout the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study hemodynamic data recovery characteristics and adverse effects if any.Timepoint: Hemodynamic data during the procedure and recovery characteristics and adverse effects at end of the procedure are seen. | — |
Countries
India
Contacts
Public ContactDr Swarnamba UN
Karnataka Institute Of Medical Sciences Hubli
Outcome results
None listed